Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Peter Croucher
Multiple Myeloma
Jing Yang
Myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Lev Kats
myeloma and epigenetics
John Leonard
lymphoma research
Jing Fu
myeloma
Siegfried Janz
Myeloma immunotherapy
Tanya Siddiqi
clinical trial access
F. Lennie Wong
Equity in Access
Lawrence Boise
CART and myeloma
Qing Yi
Novel CAR-T
Alfred Garfall
myeloma immunotherapy
Jun Qi
Myeloma
Madhav Dhodapkar
multiple myeloma immunotherapy
Urvi Shah
Diet and myeloma
Nizar Bahlis
Myeloma immunotherapy
Fenghuang Zhan
Myeloma and bone disease
Simona Colla
Myeloma biology
Brian Walker
smoldering myeloma, MGUS
Bruno Paiva
smoldering myeloma
Noemí Puig Morón
Myeloma
Michaela Reagan
Multiple Myeloma
Eugenio Morelli
Myeloma
Armin Rashidi
gut bacteria and transplant success
Ricky Johnstone
lymphoma and myeloma
Christopher Flowers
clinical trial access
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Sham Mailankody
Myeloma immunotherapy clinical trials
Ruben Carrasco
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Paul Beavis
immunotherapy in myeloma
Jianhua Yu
myeloma immunotherapy
Suzanne Lentzsch
Myeloma
William Matsui
Myeloma
Mala Shanmugam
myeloma
Carl June
CAR T immunotherapy
Caroline Arber
myeloma CAR-T
Matteo Bellone
Smoldering multiple myeloma
Jonathan Licht
DNA biology, myeloma